Trial Profile
Cough Among Hypertensive Patients Treated With Telmisartan, Who Had to Stop Previous ACE-i Treatment Due to Cough.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 27 Nov 2012
Price :
$35
*
At a glance
- Drugs Telmisartan (Primary)
- Indications Hypertension
- Focus Adverse reactions
- Acronyms COUGH
- Sponsors Bayer
- 09 Feb 2011 Actual end date (Sep 2010) added as reported by ClinicalTrials.gov.
- 09 Feb 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 14 Dec 2010 Planned End Date changed from 1 Nov 2010 to 1 Feb 2011 as reported by ClinicalTrials.gov.